Differential changes in induced seizures after hippocampal treatment of rats with an antisense oligodeoxynucleotide to the GABA A receptor 2 subunit [Eur. J. Pharmacol., 340 (1997) 153-160]

By Karle J.   Laudrup P.   Sams-Dodd F.   Mikkelsen J.D.   Nielsen M.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 367-367

Elsevier

Access to resources Recommend Favorite

Treatment with an antisense oligodeoxynucleotide to the GABA A receptor 2 subunit increases convulsive threshold for -CCM, a benzodiazepine 'inverse agonist', in rats

By Tai-jun Z.   Rosenberg H.C.   Chiu T.H.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite

An antisense oligodeoxynucleotide to -opioid receptors inhibits -opioid receptor agonist-induced analgesia in rats

By Chen X.-H.   Adams J.U.   Geller E.B.   DeRiel J.K.   Adler M.W.   Liu-Chen L.-Y.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 105-108

Elsevier

Access to resources Recommend Favorite

Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats

By Engelmann M.   Landgraf R.   Lorscher P.   Conzelmann C.   Probst J.C.   Holsboer F.   Reul J.M.H.M.  

European Journal of Pharmacology, Vol. 361, Iss. 1, 1998-11 ,pp. : 17-26

Elsevier

Access to resources Recommend Favorite

Pharmacological Agents, Hippocampal EEG, and Anticonvulsant Effects on Soman-Induced Seizures in Rats

By Myhrer T.   Skymoen L.R.   Aas P.  

Neurotoxicology, Vol. 24, Iss. 3, 2003-06 ,pp. : 357-367

Elsevier

Access to resources Recommend Favorite